CLINICALREVIEW
Trial timeline revised
Compare the current record with its prior registry version.
ClinicalTrials.govMonitoring, configured for your team
One watch across the sources your team checks by hand.
Tell us which drugs and competitors matter. We configure a watch across trial registries, FDA records, publications, patents, SEC filings, and relevant public data releases. You get one source-linked read of the changes that matter.
Source-linked updates
Daily or weekly reads
Priority-gated alerts
ASSET WATCH
ILLUSTRATIVE VIEW
YOUR WATCHLIST
Changes to review
REGULATORYREVIEW
Product label updated
Inspect the section change before updating the team brief.
DailyMed SPLEVIDENCEDIGEST
New publication linked
Check its relevance to the watched asset and indication.
Publication recordIllustrative signal types. Actual updates depend on source coverage and refresh cadence.
One place to see the change, inspect the source, and decide what happens next.
How it works
From your watchlist to a working monitor.
Watchtower is set up around the assets and decisions your team actually owns.
Choose what to follow
Share the products, competitors, and companies that matter, plus the questions your team needs answered.
We prepare the coverage
We match the right asset identities, load available source data, check readiness, and configure the watch from your perspective.
Get a decision read
Receive a daily or weekly digest. Optional event alerts flag qualifying changes between regular reads.
Each watch has a review cadence and priority threshold. Event alerts follow those settings and the publication cadence of each source.
What comes into view
A wider watch, without a wider reading list.
We match an asset across source identities, track relevant changes, and keep the underlying record close to every signal. Your setup starts with a coverage and freshness check for the assets you name.
Explore the source map See a source-linked exampleClinical registries
ClinicalTrials.gov, EU CTIS, and WHO ICTRP: trial status, enrollment, dates, results, and registry changes.
Regulatory and safety
Drugs@FDA, Orange Book, DailyMed, and FDA safety, recall, and shortage records: decisions, label revisions, and risks.
Research and patents
OpenAlex, Europe PMC, NIH RePORTER, and USPTO records: new evidence, research activity, and IP developments.
Market and company data
CMS and Medicaid datasets, SEC EDGAR filings, and public news: access, utilization, pricing, and company disclosures.
Not every source updates daily or produces an alert. Coverage depends on the asset, source publication schedule, matching confidence, and usage rights. Watchtower shows freshness and gaps instead of treating missing data as zero.
The manual workload
The checking adds up before the analysis begins.
Each asset can mean another pass through trial registries, agency pages, publications, filings, and data releases. Then someone still has to match names, compare records, decide what matters, and circulate the evidence.
Scope your team’s watchIllustrative scanning workload
5 assets × 6 sources × 2 checks per week
60 source checks each week
At five minutes per check, that is five hours of scanning before comparing changes or writing a brief. These are example inputs, not a measured customer saving.
Watchtower handles the repeat checking and assembles a prioritized, source-linked read. Your team reviews the changes that warrant judgment.
Built for review
A signal is the start of the conversation.
Each read helps your team answer three practical questions:
- What changed? A concise summary of the source update.
- Why does it matter? Context for the watched asset and your perspective.
- What next? A reviewable action, with a path back to the evidence.
Brand-level and molecule-level evidence stay distinct, so shared science is not presented as exclusive to one brand.
Get started
Tell us what to watch.
Share the assets and changes your team cares about. We’ll review your request and follow up to scope a monitoring setup.
01 / YOUR ASSETS
02 / YOUR PRIORITIES
03 / YOUR CADENCE